FindTrial
Sign In

The mechanism of TIM-3/TSGL-Ig negatively regulates liver sinusoidal endothelial cells alleviating ischemia and reperfusion injury in liver transplantation

The mechanism of TIM-3/TSGL-Ig negatively regulates liver sinusoidal endothelial cells alleviating ischemia and reperfusion injury in liver transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023126
Enrollment
Unknown
Registered
2019-05-12
Start date
2019-05-11
Completion date
Unknown
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver transplantation

Interventions

Case series:Nil

Sponsors

the First Affiliated Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients aged over 18 years old.

Exclusion criteria

Exclusion criteria: no combined kidney and liver transplantation; no re-transplantation

Design outcomes

Primary

MeasureTime frame
Liver metabolite;cytokines;—

Countries

China

Contacts

Public ContactQi Ling

the First Affiliated Hospital, School of Medicine, Zhejiang University

11418188@zju.edu.cn+86 13819195520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026